58%

New PSMAddition data show 58% lower risk of PSA progression with Pluvicto in metastatic hormone-sensitive prostate cancer

More durable, deeper PSA response in patients treated with Pluvicto plus standard of care (ARPI + ADT) vs. SoC aloneDeep…

2 weeks ago

New World Lupus Federation Global Survey Finds 58% Know Very Little or Nothing About Lupus

Low familiarity and ongoing misconceptions underscore the need for increased education and broader visibility, building on more than a decade…

4 weeks ago

India Deep Tech Alliance Issues Inaugural Report Showing AI Funding Jumps 58% in 2025, Fast-Tracks $1B USD Investment to AI Startup Funding

Report maps India AI and deep tech investment surge and next wave of ecosystem funding priorities.Total IDTA Capital Commitments Now…

3 months ago